2 results
Approved WMOCompleted
To demonstrate the additive IOP lowering effect of SIMBRINZA (dosed BID) when added to DUOTRAV solution in subjects with open-angle glaucoma or ocular hypertension.
Approved WMORecruiting
The primary objective of the study is to assess the clinical efficacy of selatogrel when self-administered upon occurrence of symptomssuggestive of an acute myocardial infarction (AMI) in subjects at risk of having a recurrent AMI.The secondary…